MedPath

A randomized controlled trial evaluating effects on health for individuals with mobility disability: eHealth vs. standard care

Not Applicable
Completed
Conditions
Self-reported mobility disability
Signs and Symptoms
Mobility disability
Registration Number
ISRCTN22387524
Lead Sponsor
Karolinska Institute
Brief Summary

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29703242 protocol 2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/32014846 results (added 06/02/2020) 2022 Results article in https://doi.org/10.1371/journal.pone.0263173 (added 08/06/2023) 2020 Results article in https://doi.org/10.1186/s12889-020-09830-y Secondary analysis (added 08/06/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
110
Inclusion Criteria

1. Classified with a mobility disability, acquired within the past three years
2. Aged 18-35 years

Exclusion Criteria

1. Problems walking

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evels of moderate to vigorous physical activity (MVPA) measured by the Actigraph GT3X+ accelerometer at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath